Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Columbia University Irving Medical Center · Cardiovascular Research Foundation · +38 more institutions
Abstract
Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and…
Citation impact
- FWCI
- 39.65
- Percentile
- 100%
- References
- 116
Authors
55- RTRebecca T. HahnCorresponding
Columbia University Irving Medical Center, Cardiovascular Research Foundation
- MLMatthew Lawlor
Columbia University Irving Medical Center
- CJCharles J. Davidson
Northwestern University
- VBVinay Badhwar
West Virginia University
- ASAnna Sannino
Heart Hospital Baylor Plano, Federico II University Hospital
Topics & keywords
- Medicine
- Clinical endpoint
- Etiology
- Clinical trial
- Tricuspid valve
- Natural history
- Regurgitation (circulation)
- Internal medicine
- Good health and well-being